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Abstract
1. The ratios of free 5α-cholestan-3β-ol and cholesterol and esterified 5α-cholestan-3β-ol
were higher in pylorus than in cardia. 2. Esterified cholesterol level was higher in cardia than
in pylorus. 3. Among the stomach cancer tiues examined free cholesterol level was higher than
in the non-cancerous. 4. Esterified 5α-cholestan-3β-o1 and cholesterol levels were lower in the
cancerous tiues than in the non cancerous.
∗PMID: 4224240 [PubMed - indexed for MEDLINE] Copyright c©OKAYAMA UNIVERSITY
MEDICAL SCHOOL
Acta Med. Okayama 20, 29 -36 (1965)
CATABOLIC METABOLISM OF CHOLESTEROL
IN STOMACH CANCER
Ken SHINZEKI, Mitsuo NARUSUE and Yasuhisa YAMAMOTO
Department flj Surgery, Okayama University Medical School,
Okayama, Japan (Director: Prof. S. Tanaka)
Received jar publication, December 2, 1965
5x-cholestan-3,9-o1 (dihydrocholesterol) was discovered by WINDAUS and
UBRIG\ and available information has given rise to the impression that 5a-
cholestan-3p-ol is an end product of cholesterol metabolism and undergoes no
further transformation2•
Determination of 5a-cholestan-3/9-o1 has been reported by SHOENHEIMER et
al.3 and there is also a recent report on "a derivative isotope dilution method
for 5a-cholestan-3p-ol ".
Though many attempts have been made to show some correlation between
malignant tumor and sterol, the problem is still far from being solved. BAUMANN
et al.~·6 found that cholesterol when fed did not promote tumor growth, but
when applied locally in oil, might accelarate the development of cancer produced
by such agents as ultraviolet lighe or benzpyrene6• The production of skin carci-
noma in rats by ultraviolet light is preceded by local concentration of cholestero18•
BERGMANN and his associates'\ however, found that irradiated cholesterol did not
act as a carcinogen. KURODA et al.4 reported that in tumorous adrenal gland of
rats 5a-cholestan-3;9-ol was lower than in normal, and cholesterol was also
distinctly decreased. The same phenomenon was observed in adrenal gland
tumor of patients with Cushing's syndrome. This investigation was undertaken
to clarify the catabolism of cholesterol in gastric carcinoma.
MATERIALS AND METHODS
Materials: Specimens of stomach were obtained at Okayama University
Hospital. Table 1 shows the cases of stomach cancer, the parts of specimens
obtained, and histological diagnosis.
Cancerous and non-cancerous tissues were taken separately from the same
stomach, which were histologically examined. Stomach cancer tissue had much
necrotic tissue which was macroscopically re:TIoved as much as possible.
Non-cancerous tissues were taken from distant parts from the cancer; for
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instance, from the cardia in the case of pyloric cancer. Fig. 1 shows a case of
pyloric carcinoma.
Acetic acid·C14 (5.0 mclm mol) was diluted with 7 ml of unlabelled acetic
anhydride. Cholesterol was purified before the use and 5a-cholestan-3j1-ol was
donated by Shionogi Research Laboratory. With these compounds acetyl deriva-
tives were also prepared.
Extraction of sterol: Cancerous and non-cancerous tissues were weighed
on a chemical balance and homogenized in the ethanol-ethyl ether mixture (3: 1,
vIv). The tissues were extracted twice by refluxing with 20 volumes of the
ethanol-ethyl ether solution for one hour each. After condensing the combined
ethanol-ethyl ether solution to half volume in vacuo, an equal amount of water
was added and then extracted three times with equal volume of petroleum ether.
The combined petroleum ether extract was washed with water and dried over
anhydrous sulfate. After evaporation of the petroleum ether in vacuo, the re-
sidue was dissolved with a small amount of n-hexane and chromatographed on
silicic acid to separate the free sterol from the esterified one by the procedure
described by HANAHAN et a[.lO,ll. The sterol ester was hydrolyzed with 10 per
cent KOH-ethanol for one hour at 85°C on a steam bath. The hydrolysate was
extracted three times with petroleum ether. The combined petroleum ether
extract was washed with water and evaporated in vacuo as described above.
The dried residue and free sterol previously eluted from silicic acid chromato-
graphy were analysed for 5a-cholestan-3,9-ol and cholesterol.
Digitonin precipitation was carried out by the method of SCHOENHEIMER et
al. 12, and then digitonide was split with dry pyridine13•
Derivative isotope dilution method : Both the crystalline and non-crystal-
line sterol fractions were transferred to the test tube (8 X 90 mm), and dried
completely in Abderhalden's apparatus for 80 min. To each tube 50 micro liters
of acetic anhydride-1-CH were added, and a small funnel holding a glass bead
on its hole was placed in the mouth of the test tube. The test tube was heated
on a paraffine bath maintained at 142-145°C for 90 min. and was then cooled.
The content of each tube was transferred with chloroform to the 100 ml round-
bottom flask containing 50 mg of 5a-cholestan-3p-ol acetate and cholesteryl
acetate, and 5 ml of methanol were added to the flask. The chloroform-methanol
mixture was removed by vacuum distillation. The residue was dissolved with a
small amount of chloroform, and then 5 ml of methanol was added and evapo-
rated. This procedure was repeated twice. The sterol residue was transferred
to a small vial and dissolved in a 10 ml of chloroform solution containing about
0.4 g of perbenzoic acid. The solution was kept at room temperature in the
dark for two hours, and was then washed with 5 per cent Na2COa to remove
the excess perbenzoic acid. The chloroform solution was diluted with 20 ml of
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ethyl ether, then dried in vacuo. The residue, dissolved in petroleum ether,
was transferred on a 10 g column of aluminium oxide (Merck) which was
activated at 180°C overnight. The column was developed with 100 ml of petro-
leum ether and the eluate was discarded. Radioactive stanol was eluted with
300 ml of petroleum ether containing 10 per cent of benzene. The eluate was
evaporated to dryness and recrystallized twice with acetone-methanol (1: 1).
Then 100 ml of 20 per cent benzene in petroleum ether were eluted and dis-
carded. Finally, radioactive epoxide cholesteryl acetate was eluted with 300 ml
of 100 per cent benzene. The eluate was distilled in vacuo, and then the
residue was recrystallized twice with methanol-water (1 : 1).
The redioactive stanol eluted by 10 per cent benzene in petroleum ether was
5a-cholestan-3fi-ol acetate, and the purity was checked by determining its melting
point. Epoxide cholesteryl acetate was an a and fi compound and its melting
point was at 110°C (softened at 86°C).
Determination of C14-radioactivity: 30-40 mg of the C14-5a-cholestan-
3p-ol acetate and 2-5 mg of epoxide cholesteryl acetate were dissolved in 15 ml
toluene containing 1.5 ml of 1,4-bis 2-(5-phenyloxazolyl)-benzene and 40 mg
of 2,5-diphenyloxazol, and its C14 was assayed by the liquid scintillation spectro-
meter, Packard Tri-Carb Model 314a.
Calculation: The calculation was carried out by using the following
equation.
m of DHC = (Mol. wt. DHC) X (Total cpm for Carrier)
g (Mol. wt. DHC-Ac) X (cpm for DHC-Ac-Stand./mg)
and
mg of cholesterol =
(Mol. wt. Epox-Ac) X (Mol. wt. Chol.) X (Total cpm for Carrier)
(Mol. wt. Chol.-Ac) X (Mol. wt. DHC-Ac) X (cpm for DHC-Ac-Stand./mg)
DHC: dihydrocholesterol: 5a-cholestan-3;9-ol
Epox-Ac: epoxide cholesteryl acetate
Chol.: cholesterol
Chol.-Ac: cholesteryl acetate
DHC-Ac-Stand.: 5a-cholestan-3;9-ol acetate Standard
This Standard was previously prepared by the same method as reported by
KURODA4, using 100 mg of 5a-cholestan-3;9-ol, acetylated with 200 microliters
of acetic anhydride-1-CH •
RESULTS AND DISCUSSION
Since the work of SCHOENHEIMER in 1930, 5a-cholestan-3;9-ol was studied
from the standpoint of metabolism and function in animals. Many quantitative
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methods for determining this substance were presented in the past, but these
methods were difficult to reproduce with limited materials.
KURODA et at. reported a useful method for microdetermination\ and the
attractive point of this method was the accuracy in the determination of 5~­
cholestan-3p-ol, using an isotope dilution method and polarizing cholesterol by
epoxidation to separate 5a·cholestan·3,j·ol and cholesterol with column chromato-
graphy.
for cancerous_
Fig. 1 A Case of Pyloric Cancer
Table 1 Cases of Stomach Cancer
I Body I
Cancerous Non-cancerous
Case Age Sex Histodiagnosis Tissuesweight
obtained from

























Tables 2 and 3 show 5a-cholestan-3p'01 (DHC) and cholesterol in stomach
cancer tissues. The case number is the same as in Table 1. Table 4 shows
the ratio of 5a-cholestan-3/9-ol to cholesterol, and does not mean the absolute
sterol amount.
The data in Tables 2 and 3 are shown by the unit of microgram per 100 g of
tissue weight. These data did not indicate any characteristic results for stomach
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Table 2 5a-ChoJestan-3p-ol




Free Ester Free &ter
I1 0.076 0.142 0.025 0.1552
I
0.086 0.293 0.026 0.076
3
I
0.123 0.210 0.047 0.060
.. ......... ....... ._-- ..............
4 0.037 0.075 0.069 0.164
5 0.044 0.179 0.070 0.120
6 0.054 0.126 0.087 0.159
.....
(unit: microgram per 100 g tissue)
The values shown in 1---1 were obtained from pylorus
...............
and in : j from cardia.
..... -..... ~ ... .'
Table 3 Cholesterol
in Non-cancerous and Cancerous Tissues in Stomach
Non-cancerous Cancerous
Case
Free Ester Free Ester
1 0.173 0.536 0.556 0.933
2 0.193 1.024 0.213 1.172
3 0.437 0.866 0.204 0.720
4 1.237 0.399 1.357
5 1.574 0.299 1.017
6 1.656 0.279 0.975
(unit: microgram per 100 g tissue)
The values shown in 1=1 were obtained from pylorus
and in from cardia.
cancer. This was probably due to the individual differences of patients. More-
over, it is presumed that non-cancerous tissue obtained from the same specimen
was influenced by cancerous environments.
The data in Table 4 are represented by percentage ratio, and influences of
many conditional differences were probably smaller than in Table 2 and Table
3. Among the non-cancerous tissues, the differences of values were observed
between cardia and pylorus. In pylorus, the percentage ratio of free 5a-cholestan-
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Table 4 The Ratio of 5a:-Cholestan-3,B-ol and Cholesterol
in Non-cancerous and Cancerous Tissues of Stomach
I Non-cancerous Cancerous
I
Case I Free Ester Free I EsterI
i DHC Chole- DHC Chole- DHC Chole-I DHC Chole-
I sterol sterol sterol sterol
1 8.2 18.7 15.3 57.8 1.5 33.3 9.3 55.8
2 5.6 12.1 18.3 64.0 1.8 14.2 5.1 78.2
3 7.7 23.7 13.1 54.1 4.5 19.8 5.8 69.8
4 2.6 6.3 5.2 85.8 3.3 19.6 10.4 66.51
5 2.3 5.0 9.4 82.4 5.1 20.4 7.8 66.7 I
6 I 2.7 7.9 6.1 83.2 5.4 23.7 10.0 61.0 I
(DHC+Cholesterol=100 per cent)
Other steroids are omitted in this table.
The val~~~..~~~~~ in 1=1 were obtained from pylorus
and in : : from cardia.
3p-ol and cholesterol, and esterified 5a'-cholestan-3p-ol was higher than that in
cardia, but esterified cholesterol in pylorus was lower than that in cardia. It
suggests that the digesting movement of pylorus might be a potent factor, and
pylorus had more active movement than cardia. Also the cholesterol metabolism
in pylorus was more active than in cardia.
Among the cancerous tissues examined free 5.2·-cholestan-3p-ol in cardia
was lower than in pylorus. Free 5.:t-cholestan-3p-ol of pyloric cancer was lower
than that of the non-cancerous pylorus. Free cholesterol of the cancerous group
was higher than that of the non-cancerous. Esterified 5.T-cholestan-3p-ol of
cardiac cancer was lower than the non-cancerous. That of pyloric cancer was
lower than the non-cancerous cardia, but was observed to be almost the same
as the non-cancerous pylorus.
It is interesting to note that among the cancerous tissues the ratio of free
cholesterol was higher than that of the non-cancerous, and esterified 5a-chole-
stan-3f9-01 and cholesterol had smaller ratios in the cancerous tissues than in the
non-cancerous tissues, while any definite indication could hardly be discerned
from Table 2 and Table 3. It suggests that esterified cholesterol might be
mainly used for catabolic metabolism in cancerous tissues. These phenomena
were similiar to the report of KURODA et at. about adrenal gland"
KELLER suggested an altered sterol metabolism in adrenal tumor tissue14•
HAVEN et at. lD and BEGG16 reported that rats bearing Walker-carcinoma and
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Jensen sarcoma have adrenal hyperplasia and lower adrenal cholesterol content
than that of normal. GORE et al17• found that the rat ascites tumor and mouse
Ehrlich ascites carcinoma are unable to utilize acetate for the sterol synthesis.
From the fact that a smaller amount of esterified cholesterol was contained
in cancerous tissue, it was considered that the cholesterol metabolism was more
active in the cancerous tissues than in the non-cancerous tissues.
SUMMARY
1. The ratios of free 5a-cholestan-3p-ol and cholesterol and esterified 5a-
cholestan-3p-ol were higher in pylorus than in cardia.
2. Esterified cholesterol level was higher in cardia than in pylorus.
3. Among the stomach cancer tissues examined free cholesterol level was
higher than in the non-cancerous.
4. Esterified 5'x·cholestan-3J9-o1 and cholesterol levels were lower in the
cancerous tissues than in the non-cancerous.
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